Guidelines for cryoprecipitate transfusion

VOL. 49 NO. 8, OCTOBER2007BC MEDICAL JOURNAL441 ABSTRACT: The literature showsthere is often inappropriate use of blood products, including cryo -precipitate plasma, because of in -adequate education of for cryoprecipitate trans-fusion have been developed by theTransfusion Medicine Advisory Groupof British Columbia to educate clini-cians and address transfusion prac-tices in the province. These guide-lines are based on a MEDLINE search and consultation with hema -to pathologists and clinicians. At pre-sent, transfusion of cryoprecipitateis indicated for hypofibrinogen emia/dysfibrinogenemia, von Willebranddisease, hemophilia A, factor XIII deficiency, and management ofbleeding related to thrombolytictherapy. cryoprecipitate should notbe used to prepare fibrin glue or totreat sepsis. The transfusion Medicine Ad -visory Group (TMAG) of BChas prepared Guidelines to pro-vide physicians with current informa-tion on the appropriate use of cryopre-cipitate plasma.

Whole blood is centrifuged at high speed, allowing separa-tion of plasma, red blood cells (RBCs), and the buffy coat layer (platelets, white blood cells, some RBCs and plasma). Plasma is frozen within 24 hours of collection and is des-ignated as frozen plasma (FP). It is prepared for use by thaw-ing at 37°C, a process that can take up to 30 ...

Loading..

Tags:

  Blood

Information

Related search queries